{"id":"W4229034592","doi":"10.25251/skin.6.supp.4","title":"Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor, in Moderate to Severe Plaque Psoriasis: 52-Week Efficacy Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials","year":2022,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Bristol-Myers Squibb","keywords":"Plaque psoriasis; Medicine; Psoriasis; Internal medicine; Pharmacology; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004356343,0.0004063609,0.00117653,0.0002626676,0.0006476456,0.00002730973,0.0005861344,0.000173298,0.0003226339],"category_scores_gemma":[0.001939571,0.0002206062,0.0001459795,0.0005127887,0.0002471565,0.0001142936,0.0001432318,0.000908244,0.0000151881],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001697315,"about_ca_system_score_gemma":0.0002427586,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008022597,"about_ca_topic_score_gemma":0.0004651153,"domain_scores_codex":[0.9931063,0.004324828,0.001458792,0.0003834596,0.000255963,0.0004706522],"domain_scores_gemma":[0.9937964,0.004494668,0.0009225261,0.0004651191,0.0001984817,0.0001228115],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3042119,0.005311353,0.0003031808,0.0000236961,0.003779644,0.003801946,0.07836991,0.003346244,0.2987708,0.0001625123,0.1008008,0.2011179],"study_design_scores_gemma":[0.3430208,0.08532566,0.004715336,0.001957677,0.01015873,0.07143686,0.05474647,0.0002951007,0.2231353,0.007618408,0.1947579,0.002831766],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9787339,0.009517833,0.00003719017,0.008610722,0.001462339,0.0007931612,0.000682736,0.00002449116,0.0001376037],"genre_scores_gemma":[0.996147,0.001196993,0.0001015187,0.001195563,0.0006737713,0.00002345427,0.0001947079,0.00003964489,0.0004273051],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1982862,"threshold_uncertainty_score":0.8996059,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04009431060346913,"score_gpt":0.302258072534325,"score_spread":0.2621637619308559,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}